ditrans,polycis-undecaprenyl phosphate

(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl dihydrogen phosphate

UFPHFKCTOZIAFY-NTDVEAECSA-N CHEBI:60468 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: UFPHFKCTOZIAFY-NTDVEAECSA-N
InChI Key: UFPHFKCTOZIAFY-NTDVEAECSA-N
IUPAC name: (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-yl dihydrogen phosphate
Preferred name: ditrans,polycis-undecaprenyl phosphate
INN name: —
Synonym: ditrans,octacis-Undecaprenyl phosphate
ChEBI: CHEBI:60468

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

wild_type_vs_patA_deletion